Nerve tumor in children: better tolerable chemotherapy without loss of efficacy

ST. ANNA CHILDREN'S CANCER RESEARCH INSTITUTE - June 21, 2021

"The European Neuroblastoma Study Group of the International Society of Pediatric Oncology (SIOPEN), has now compared two of the most effective combination therapies in an international study, coordinated by St. Anna Children's Cancer Research Institute (St. Anna CCRI). The result: equal efficacy, but significantly lower rates of side effects with the therapy regimen considered the standard of the European Neuroblastoma Group SIOPEN"

Read article>>